Commonwealth Equity Services LLC Buys New Position in Enovis Co. (NYSE:ENOV)

Commonwealth Equity Services LLC purchased a new stake in Enovis Co. (NYSE:ENOV) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,163 shares of the company’s stock, valued at approximately $402,000.

Several other large investors have also bought and sold shares of ENOV. UMB Bank n.a. grew its stake in shares of Enovis by 128.2% in the 4th quarter. UMB Bank n.a. now owns 778 shares of the company’s stock worth $34,000 after acquiring an additional 437 shares in the last quarter. Pinnacle Bancorp Inc. boosted its holdings in Enovis by 54.5% during the fourth quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company’s stock worth $37,000 after purchasing an additional 300 shares during the last quarter. FMR LLC grew its position in Enovis by 20.5% in the 3rd quarter. FMR LLC now owns 2,840 shares of the company’s stock worth $122,000 after purchasing an additional 484 shares in the last quarter. XTX Topco Ltd purchased a new stake in Enovis in the 3rd quarter valued at about $217,000. Finally, Legacy Capital Wealth Partners LLC bought a new position in shares of Enovis during the 4th quarter worth approximately $228,000. 98.45% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $64.00 target price on shares of Enovis in a report on Wednesday, April 2nd.

Enovis Price Performance

Shares of NYSE:ENOV opened at $32.52 on Monday. The company has a market capitalization of $1.85 billion, a P/E ratio of -14.85 and a beta of 1.86. The company’s 50-day moving average is $40.90 and its 200 day moving average is $43.09. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.12 and a current ratio of 2.27. Enovis Co. has a fifty-two week low of $31.00 and a fifty-two week high of $62.79.

Enovis (NYSE:ENOV) last released its earnings results on Wednesday, February 26th. The company reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.06. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. The firm had revenue of $560.98 million for the quarter, compared to analysts’ expectations of $555.14 million. On average, equities research analysts forecast that Enovis Co. will post 2.79 earnings per share for the current year.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.